SUBSCRIBE
SUBSCRIBE

TMX Newsfile

IN THE PRESS
Press Releases
TempraMed Launches New Product “VIVI Med(TM),” Unlocking New Growth Opportunities in High-Value Biologics and Injectable Medications
January 23, 2026
 · 
6 min read
Press Releases
MustGrow Closes $2.0 Million Non-Brokered LIFE Offering
January 23, 2026
 · 
5 min read
Press Releases
Cardiol Therapeutics Announces Closing of Bought Deal Financing and Full Exercise of Over-Allotment Option for Gross Proceeds of $14.85 Million
January 23, 2026
 · 
6 min read
Press Releases
Defence Therapeutics Sharpens Strategic Focus on Precision Drug Delivery to Unlock the Full Potential of Cancer Biologics
January 21, 2026
 · 
4 min read
Press Releases
Phio Pharmaceuticals Announces Key Tumor Response Data from all Cohorts in Intratumoral PH-762 Dose Escalation Cutaneous Carcinoma Trial
January 20, 2026
 · 
1 min read
Press Releases
BioVaxys Reports Positive Clinical Study Results from Phase 1B/2 PESCO Trial of MVP-S with Pembrolizumab (Keytruda (TM)) and Low-Dose Cyclophosphamide for Patients with Recurrent Epithelial Ovarian Cancer (EOC)
January 20, 2026
 · 
1 min read
Press Releases
Therma Bright Sells an Additional 200-Units of Venowave(TM) to Strategic Distribution Partner Gen-X Med
January 20, 2026
 · 
1 min read
Press Releases
Entheon Announces Execution of Business Combination Agreement with Nutravisor
January 19, 2026
 · 
11 min read
Press Releases
Hemostemix Receives FDA Support for Its Basket Protocol Approach
January 16, 2026
 · 
8 min read
Press Releases
Cardiol Therapeutics Inc. Announces Bought Deal Financing for Gross Proceeds of $13.5 Million
January 16, 2026
 · 
8 min read
Load More
15 Toronto St., Suite 601 Toronto ON M5C 2E3 US
Tel: 416-806-1750
Visit website
Email Us